Addus HomeCare Debt to Equity Ratio 2010-2025 | ADUS

Current and historical debt to equity ratio values for Addus HomeCare (ADUS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Addus HomeCare debt/equity for the three months ending March 31, 2025 was 0.20.
Addus HomeCare Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.41B $1.00B 0.41
2024-12-31 $0.44B $0.97B 0.46
2024-09-30 $0.21B $0.95B 0.22
2024-06-30 $0.20B $0.92B 0.21
2024-03-31 $0.29B $0.73B 0.40
2023-12-31 $0.32B $0.71B 0.45
2023-09-30 $0.35B $0.68B 0.51
2023-06-30 $0.26B $0.67B 0.39
2023-03-31 $0.28B $0.65B 0.44
2022-12-31 $0.30B $0.63B 0.48
2022-09-30 $0.33B $0.62B 0.54
2022-06-30 $0.37B $0.60B 0.61
2022-03-31 $0.40B $0.59B 0.69
2021-12-31 $0.37B $0.57B 0.65
2021-09-30 $0.37B $0.56B 0.66
2021-06-30 $0.35B $0.54B 0.63
2021-03-31 $0.35B $0.53B 0.66
2020-12-31 $0.37B $0.52B 0.72
2020-09-30 $0.19B $0.51B 0.37
2020-06-30 $0.17B $0.50B 0.34
2020-03-31 $0.16B $0.49B 0.33
2019-12-31 $0.16B $0.48B 0.34
2019-09-30 $0.15B $0.47B 0.32
2019-06-30 $0.12B $0.29B 0.41
2019-03-31 $0.10B $0.28B 0.35
2018-12-31 $0.08B $0.27B 0.30
2018-09-30 $0.16B $0.27B 0.61
2018-06-30 $0.16B $0.19B 0.84
2018-03-31 $0.09B $0.18B 0.51
2017-12-31 $0.10B $0.18B 0.54
2017-09-30 $0.10B $0.17B 0.56
2017-06-30 $0.09B $0.17B 0.52
2017-03-31 $0.07B $0.17B 0.45
2016-12-31 $0.07B $0.16B 0.46
2016-09-30 $0.08B $0.15B 0.53
2016-06-30 $0.10B $0.15B 0.64
2016-03-31 $0.09B $0.14B 0.61
2015-12-31 $0.04B $0.14B 0.31
2015-09-30 $0.06B $0.14B 0.42
2015-06-30 $0.05B $0.13B 0.40
2015-03-31 $0.05B $0.13B 0.40
2014-12-31 $0.05B $0.13B 0.41
2014-09-30 $0.05B $0.12B 0.43
2014-06-30 $0.05B $0.12B 0.38
2014-03-31 $0.05B $0.12B 0.40
2013-12-31 $0.05B $0.11B 0.44
2013-09-30 $0.04B $0.11B 0.39
2013-06-30 $0.05B $0.11B 0.41
2013-03-31 $0.04B $0.11B 0.40
2012-12-31 $0.06B $0.09B 0.59
2012-09-30 $0.06B $0.09B 0.69
2012-06-30 $0.06B $0.09B 0.70
2012-03-31 $0.07B $0.09B 0.77
2011-12-31 $0.07B $0.09B 0.79
2011-09-30 $0.08B $0.08B 0.92
2011-06-30 $0.08B $0.09B 0.88
2011-03-31 $0.07B $0.09B 0.79
2010-12-31 $0.08B $0.09B 0.90
2010-09-30 $0.09B $0.09B 1.01
2010-06-30 $0.08B $0.08B 1.01
2010-03-31 $0.08B $0.08B 1.03
2009-12-31 $0.08B $0.08B 1.00
2009-09-30 $0.11B $0.04B 2.94
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.027B $1.155B
ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.032B 18.75
Encompass Health (EHC) United States $12.081B 25.61
DaVita (DVA) United States $10.634B 14.95
Chemed (CHE) United States $8.357B 26.26
Elanco Animal Health (ELAN) United States $6.268B 13.43
Option Care Health (OPCH) United States $5.356B 23.88
RadNet (RDNT) United States $4.356B 276.48
Amedisys (AMED) United States $3.072B 20.66
LifeStance Health (LFST) United States $2.205B 0.00
Astrana Health (ASTH) United States $1.412B 34.99
U.S Physical Therapy (USPH) United States $1.174B 30.31
Aveanna Healthcare Holdings (AVAH) United States $1.071B 61.00
Pennant (PNTG) United States $0.987B 36.24
Atai Life Sciences (ATAI) Germany $0.383B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.051B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00